Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laryngoscopy | 15 | 2022 | 707 | 2.920 |
Why?
|
Larynx | 6 | 2022 | 492 | 2.290 |
Why?
|
Laryngeal Diseases | 4 | 2021 | 243 | 1.910 |
Why?
|
Microsurgery | 5 | 2021 | 795 | 1.760 |
Why?
|
Vocal Cord Paralysis | 7 | 2022 | 272 | 1.540 |
Why?
|
Deglutition Disorders | 2 | 2024 | 625 | 1.030 |
Why?
|
Voice Disorders | 4 | 2024 | 286 | 0.950 |
Why?
|
Monitoring, Intraoperative | 3 | 2021 | 942 | 0.920 |
Why?
|
Voice Quality | 3 | 2017 | 226 | 0.910 |
Why?
|
Laryngostenosis | 2 | 2017 | 167 | 0.880 |
Why?
|
Parkinsonian Disorders | 2 | 2020 | 284 | 0.870 |
Why?
|
Vocal Cords | 8 | 2022 | 522 | 0.860 |
Why?
|
Voice | 3 | 2023 | 268 | 0.770 |
Why?
|
Dystonia | 3 | 2020 | 370 | 0.740 |
Why?
|
Aerosols | 2 | 2020 | 635 | 0.730 |
Why?
|
Dystonic Disorders | 2 | 2019 | 350 | 0.720 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2020 | 119 | 0.650 |
Why?
|
Tracheostomy | 2 | 2020 | 426 | 0.630 |
Why?
|
Hypoglossal Nerve | 2 | 2016 | 108 | 0.600 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.590 |
Why?
|
Occupations | 2 | 2017 | 515 | 0.590 |
Why?
|
Botulinum Toxins, Type A | 2 | 2013 | 237 | 0.560 |
Why?
|
Narcotics | 1 | 2019 | 336 | 0.550 |
Why?
|
Dysphonia | 3 | 2019 | 144 | 0.530 |
Why?
|
Denervation | 1 | 2016 | 265 | 0.490 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 386 | 0.490 |
Why?
|
Choice Behavior | 2 | 2017 | 824 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Electromyography | 6 | 2022 | 1394 | 0.470 |
Why?
|
Granuloma, Laryngeal | 1 | 2013 | 8 | 0.450 |
Why?
|
Medical Device Recalls | 1 | 2013 | 15 | 0.440 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.430 |
Why?
|
Patient Preference | 2 | 2017 | 924 | 0.430 |
Why?
|
Benchmarking | 1 | 2019 | 1045 | 0.430 |
Why?
|
Tongue | 1 | 2016 | 403 | 0.420 |
Why?
|
Otolaryngology | 2 | 2020 | 693 | 0.410 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2630 | 0.400 |
Why?
|
Neurofibromatoses | 1 | 2016 | 299 | 0.390 |
Why?
|
Pressure | 3 | 2021 | 1154 | 0.390 |
Why?
|
Pharynx | 1 | 2014 | 432 | 0.390 |
Why?
|
Dilatation | 1 | 2013 | 306 | 0.390 |
Why?
|
Postoperative Complications | 4 | 2022 | 15633 | 0.380 |
Why?
|
Occupational Health | 1 | 2017 | 806 | 0.370 |
Why?
|
Functional Laterality | 1 | 2017 | 2257 | 0.350 |
Why?
|
Viscosupplements | 1 | 2010 | 21 | 0.350 |
Why?
|
Occupational Diseases | 1 | 2017 | 1490 | 0.320 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1882 | 0.310 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1740 | 0.310 |
Why?
|
Temporomandibular Joint Dysfunction Syndrome | 1 | 2007 | 24 | 0.290 |
Why?
|
Equipment Design | 4 | 2021 | 3511 | 0.270 |
Why?
|
Hoarseness | 2 | 2020 | 63 | 0.270 |
Why?
|
Hyaluronic Acid | 1 | 2010 | 483 | 0.270 |
Why?
|
Facial Pain | 1 | 2007 | 120 | 0.260 |
Why?
|
Neuromuscular Agents | 1 | 2007 | 147 | 0.250 |
Why?
|
Thyroidectomy | 2 | 2015 | 908 | 0.250 |
Why?
|
Laryngoscopes | 2 | 2018 | 146 | 0.240 |
Why?
|
Stress, Mechanical | 2 | 2019 | 1674 | 0.220 |
Why?
|
Endoscopy | 1 | 2013 | 1851 | 0.210 |
Why?
|
Video Recording | 2 | 2021 | 967 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.200 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4544 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Quality of Life | 3 | 2020 | 13367 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2244 | 0.200 |
Why?
|
Esophagoscopy | 1 | 2024 | 396 | 0.200 |
Why?
|
Paresis | 1 | 2022 | 176 | 0.190 |
Why?
|
Prospective Studies | 7 | 2022 | 54423 | 0.180 |
Why?
|
Adult | 22 | 2024 | 221200 | 0.180 |
Why?
|
Humans | 41 | 2024 | 761578 | 0.180 |
Why?
|
Models, Animal | 2 | 2017 | 2112 | 0.170 |
Why?
|
Insufflation | 1 | 2020 | 62 | 0.170 |
Why?
|
Glottis | 1 | 2021 | 214 | 0.170 |
Why?
|
Injections, Intramuscular | 2 | 2013 | 554 | 0.160 |
Why?
|
Headache | 1 | 2007 | 1256 | 0.160 |
Why?
|
Sickness Impact Profile | 1 | 2019 | 299 | 0.150 |
Why?
|
Physical Examination | 1 | 2024 | 1255 | 0.150 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2578 | 0.150 |
Why?
|
Middle Aged | 17 | 2024 | 220917 | 0.140 |
Why?
|
Risk Assessment | 2 | 2017 | 23996 | 0.140 |
Why?
|
Perioperative Care | 1 | 2005 | 1036 | 0.140 |
Why?
|
Female | 26 | 2024 | 392688 | 0.140 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18255 | 0.140 |
Why?
|
Swine | 2 | 2017 | 5915 | 0.130 |
Why?
|
Male | 21 | 2024 | 360841 | 0.130 |
Why?
|
Wakefulness | 1 | 2022 | 1265 | 0.130 |
Why?
|
Laryngeal Mucosa | 1 | 2015 | 32 | 0.130 |
Why?
|
Injections | 3 | 2021 | 831 | 0.130 |
Why?
|
Myosins | 1 | 2016 | 405 | 0.120 |
Why?
|
Morphine | 1 | 2019 | 657 | 0.120 |
Why?
|
Dogs | 2 | 2016 | 3839 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15266 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12973 | 0.110 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2895 | 0.100 |
Why?
|
Laryngeal Muscles | 1 | 2013 | 107 | 0.100 |
Why?
|
Hyoid Bone | 1 | 2012 | 38 | 0.100 |
Why?
|
Aged | 10 | 2024 | 169308 | 0.100 |
Why?
|
Thyroid Cartilage | 1 | 2012 | 43 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 683 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2022 | 80646 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20099 | 0.090 |
Why?
|
Atrophy | 1 | 2016 | 1633 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1136 | 0.090 |
Why?
|
Equipment Failure | 1 | 2013 | 578 | 0.090 |
Why?
|
Hospital Costs | 1 | 2016 | 947 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 823 | 0.090 |
Why?
|
Software | 2 | 2021 | 4434 | 0.090 |
Why?
|
Needles | 1 | 2012 | 451 | 0.080 |
Why?
|
Gels | 1 | 2010 | 420 | 0.080 |
Why?
|
Logistic Models | 2 | 2021 | 13255 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9646 | 0.080 |
Why?
|
Aphasia | 1 | 2010 | 192 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3461 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4111 | 0.070 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 477 | 0.070 |
Why?
|
Masticatory Muscles | 1 | 2007 | 31 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2049 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1421 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8633 | 0.070 |
Why?
|
Molecular Structure | 1 | 2010 | 1880 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39107 | 0.060 |
Why?
|
Prevalence | 2 | 2024 | 15732 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1664 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8830 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5492 | 0.050 |
Why?
|
Endothelial Growth Factors | 2 | 2003 | 673 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3929 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2015 | 3677 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2373 | 0.050 |
Why?
|
Lymphokines | 2 | 2003 | 927 | 0.050 |
Why?
|
Electrodes | 1 | 2005 | 614 | 0.050 |
Why?
|
Fibromatosis, Aggressive | 1 | 2004 | 126 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20569 | 0.050 |
Why?
|
Animals | 5 | 2017 | 168475 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4793 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5799 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10766 | 0.050 |
Why?
|
Rhinoplasty | 1 | 2005 | 238 | 0.050 |
Why?
|
Laryngoplasty | 1 | 2021 | 50 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
Failure to Thrive | 1 | 2020 | 140 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9610 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
Apnea | 1 | 2020 | 195 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 477 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6485 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2001 | 240 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2001 | 544 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 224 | 0.040 |
Why?
|
Risk Factors | 3 | 2017 | 74212 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1779 | 0.040 |
Why?
|
Neuroglia | 1 | 2003 | 956 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 88323 | 0.030 |
Why?
|
Airway Management | 1 | 2020 | 312 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2013 | 64684 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.030 |
Why?
|
Keratin-13 | 1 | 2015 | 11 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2020 | 1147 | 0.030 |
Why?
|
Keratin-14 | 1 | 2015 | 56 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58983 | 0.030 |
Why?
|
Stroboscopy | 1 | 2015 | 62 | 0.030 |
Why?
|
Laryngeal Nerves | 1 | 2015 | 57 | 0.030 |
Why?
|
Decision Trees | 1 | 2016 | 504 | 0.030 |
Why?
|
Health Surveys | 1 | 2024 | 4061 | 0.030 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2015 | 143 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 629 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 693 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2004 | 1924 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2015 | 458 | 0.030 |
Why?
|
Retina | 1 | 2003 | 2659 | 0.020 |
Why?
|
Syringes | 1 | 2012 | 58 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2016 | 754 | 0.020 |
Why?
|
Vimentin | 2 | 2003 | 255 | 0.020 |
Why?
|
United States | 2 | 2024 | 72335 | 0.020 |
Why?
|
Protein Precursors | 1 | 2015 | 1132 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2003 | 748 | 0.020 |
Why?
|
Incidental Findings | 1 | 2015 | 697 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1118 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15843 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11076 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1722 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4772 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4920 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2004 | 9281 | 0.020 |
Why?
|
Mutation | 1 | 2010 | 30054 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5247 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9463 | 0.010 |
Why?
|
Young Adult | 2 | 2024 | 59254 | 0.010 |
Why?
|
Esthetics | 1 | 2005 | 330 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3537 | 0.010 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2003 | 127 | 0.010 |
Why?
|
Neck Pain | 1 | 2004 | 190 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.010 |
Why?
|
Contrast Media | 1 | 2015 | 5307 | 0.010 |
Why?
|
Arachnoid | 1 | 2001 | 50 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2003 | 3492 | 0.010 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2001 | 191 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7967 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10451 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2001 | 8601 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23741 | 0.010 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2003 | 699 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 592 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2645 | 0.010 |
Why?
|
Amyloid | 1 | 2001 | 841 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 867 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26127 | 0.010 |
Why?
|
Hydrocephalus | 1 | 2001 | 764 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3810 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4431 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81539 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_